DeutschNewstral
Article
jdsupra.com on 2022-10-27 17:36
PMPRB finds ultra-rare drug PROCYSBI is excessively priced
Related news
- 2021 PMPRB Annual Reportjdsupra.com
- Quebec Court finds price and revenue calculation provisions of amended PMPRB Regulations unconstitutionaljdsupra.com
- Federal Court finds PMPRB reasonably concluded Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERINjdsupra.com
- PMPRB publishes annual Meds Pipeline Monitor reportjdsupra.com
- PMPRB releases three new NPDUIS reportsjdsupra.com
- PMPRB adopts Amended Interim Guidance pending release of new guidelinesjdsupra.com
- Few significant changes made in final PMPRB Guidelinesjdsupra.com
- Innovators challenge final PMPRB Guidelines in new Federal Court applicationjdsupra.com
- PMPRB releases analytic study of Canadian oncology marketjdsupra.com
- PMPRB releases 2020 Annual Report and April 2022 NEWSletterjdsupra.com
- PMPRB releases 2022 Annual Report and March 2024 NEWSletterjdsupra.com
This Brand Brings Ultra-Rare Aged Japanese Whiskies To AmericaForbes
Queenslander finds ultra-rare sapphire worth a small fortuneSydney Morning Herald
Scholar finds rare New Testament manuscript on eBay priced at $99The Verge
Study finds rare advance for tough-to-beat pancreatic cancerThe Findlay Courier- PMPRB Update: new consultation on PMPRB Guidelines, including revised international price testsjdsupra.com
- PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicinesjdsupra.com
Scots man finds ultra-rare Rolex worth around £120,000 'sitting in drawer'The Daily Record- ENetflix is testing higher-priced 'Ultra' planseu.usatoday.com
- NRace against time for family of toddler with ultra-rare disease, whose only chance at life costs $3 millionnationalpost.com